Verrica Pharmaceuticals (VRCA)

Verrica Pharmaceuticals (VRCA) Financial Statements


Verrica Pharmaceuticals Financial Overview

Verrica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.819; its P/E ratio is -7.77; Verrica Pharmaceuticals is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 68.00K$ 8.32M$ 214.00K$ 431.00K$ 0.00
Gross Profit$ 6.00K----
EBIT$ -5.93M$ 164.00K$ -9.10M$ -7.39M$ -8.44M
EBITDA$ -5.54M$ 291.00K$ -9.00M$ -7.29M$ -8.07M
Net Income Common Stockholders$ -5.93M$ 83.00K$ -10.17M$ -8.47M$ -9.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.27M$ 39.45M$ 14.40M$ 21.90M$ 70.35M
Total Assets$ 44.72M$ 49.15M$ 63.44M$ 71.62M$ 80.13M
Total Debt$ 1.53M$ 1.59M$ 43.98M$ 43.65M$ 43.41M
Net Debt$ -32.75M$ -37.86M$ 29.58M$ 21.75M$ -26.95M
Total Liabilities$ 4.69M$ 4.38M$ 47.10M$ 46.20M$ 47.52M
Stockholders Equity$ 40.03M$ 44.77M$ 16.33M$ 25.42M$ 32.60M
Cash Flow-
Free Cash Flow$ -5.02M$ 1.75M$ -7.33M$ -8.35M$ -8.94M
Operating Cash Flow$ -4.95M$ 1.82M$ -7.18M$ -8.34M$ -8.70M
Investing Cash Flow$ 6.75M$ 2.07M$ 2.21M$ 43.01M$ 4.01M
Financing Cash Flow$ 0.00$ -16.85M$ -1.00K$ -18.00K$ -3.00K
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

Verrica Pharmaceuticals Debt to Assets

Verrica Pharmaceuticals Cash Flow

Verrica Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis